Recruiting patients for a clinical trial is challenging and often involves the same-old process of prospecting for the right patients by way of traditional media and a “do you have these symptoms” approach. It's typically an expensive, time-consuming method than often results in missed deadlines or incomplete recruiting that risks the entire drug development process.

 

Nukleus took a new approach to recruitment for a key Diabetic Retinopathy trial, drawing from a combination of demographic data and market research to develop the unique, highly impactful Seeing Spots Dalmatians creative campaign to bypass the usual boring staid appeals. Driving the message home though a wide base of marketing tools and in novel media contexts attracted the high-quality—and the necessary high quantity—of potential patients to fill every “spot” in the trials earlier than expected.